Cargando…

Vascular Inflammation and Cardiovascular Burden in Metastatic Breast Cancer Female Patients Receiving Hormonal Treatment and CDK 4/6 Inhibitors or Everolimus

Background: Chemotherapy regimens for breast cancer treatment can promote vascular dysfunction and lead to high cardiovascular risk. Purpose: To investigate the cardiovascular burden and vascular inflammation in metastatic breast cancer patients receiving CDK 4/6 inhibitors or everolimus in addition...

Descripción completa

Detalles Bibliográficos
Autores principales:	Papageorgiou, Christos, Zagouri, Flora, Tampakis, Konstantinos, Georgakopoulou, Rebecca, Manios, Efstathios, Kafouris, Pavlos, Benetos, Georgios, Koutagiar, Iosif, Anagnostopoulos, Constantinos, Dimopoulos, Meletios A., Toutouzas, Konstantinos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7959765/ https://www.ncbi.nlm.nih.gov/pubmed/33732735 http://dx.doi.org/10.3389/fcvm.2021.638895

Ejemplares similares

Carotid Artery Temperature Reduction with Statin Therapy in Patients with Familial Hyperlipidemia Syndromes
por: Benetos, Georgios, et al.
Publicado: (2021)

MicroRNAs as Potential Predictors of Response to CDK4/6 Inhibitor Treatment
por: Andrikopoulou, Angeliki, et al.
Publicado: (2021)

Aromatase and CDK4/6 Inhibitor-Induced Musculoskeletal Symptoms: A Systematic Review
por: Andrikopoulou, Angeliki, et al.
Publicado: (2021)

SARS-CoV-2 neutralizing antibodies after first vaccination dose in breast cancer patients receiving CDK4/6 inhibitors
por: Zagouri, Flora, et al.
Publicado: (2021)

CDK4/6 Inhibitors and Arthralgia: A Single Institution Experience
por: Andrikopoulou, Angeliki, et al.
Publicado: (2021)

Impact of CDK4/6 Inhibitors on Aromatase Inhibitor-Associated Musculoskeletal Syndrome (AIMSS) in the Adjuvant Setting
por: Skafida, Efthymia, et al.
Publicado: (2023)

Activated Clotting Time as a Marker of Inflammation in Hospitalized Patients
por: Papageorgiou, Christos, et al.
Publicado: (2020)

Clinical Perspectives of ERCC1 in Bladder Cancer
por: Koutsoukos, Konstantinos, et al.
Publicado: (2020)

Circulating tumor DNA-based predictive biomarkers in breast cancer clinical trials: a narrative review
por: Fiste, Oraianthi, et al.
Publicado: (2020)

Occupational Exposure and Multiple Myeloma Risk: An Updated Review of Meta-Analyses
por: Georgakopoulou, Rebecca, et al.
Publicado: (2021)

Predictors of colorectal cancer screening awareness among people working in a hospital environment
por: Michopoulos, Spyridon, et al.
Publicado: (2017)

Continuing Cancer Therapy through the Pandemic While Protecting Our Patients: Results of the Implementation of Preventive Strategies in a Referral Oncology Unit
por: Liontos, Michalis, et al.
Publicado: (2021)

Olaratumab administered in two cases of phyllodes tumour of the breast: end of the beginning?
por: Kyriazoglou, Anastasios, et al.
Publicado: (2019)

Low titers of SARS-CoV-2 neutralizing antibodies after first vaccination dose in cancer patients receiving checkpoint inhibitors
por: Terpos, Evangelos, et al.
Publicado: (2021)

Secondary Alopecia Neoplastica Mimicking Alopecia Areata following Breast Cancer
por: Skafida, Efthymia, et al.
Publicado: (2020)

Metastatic Hepatic Epithelioid Hemangioendothelioma Treated with Olaratumab: A Falling Star Rising?
por: Kyriazoglou, Anastasios, et al.
Publicado: (2020)

Brain Oscillations Elicited by the Cold Pressor Test: A Putative Index of Untreated Essential Hypertension
por: Papageorgiou, Christos, et al.
Publicado: (2017)

Treatment of early uterine sarcomas: disentangling adjuvant modalities
por: Zagouri, Flora, et al.
Publicado: (2009)

The Emerging Role of Immunotherapy in Intrahepatic Cholangiocarcinoma
por: Fiste, Oraianthi, et al.
Publicado: (2021)

Immunological Response to COVID-19 Vaccination in Ovarian Cancer Patients Receiving PARP Inhibitors
por: Liontos, Michalis, et al.
Publicado: (2021)

Pembrolizumab in endometrial cancer: Where we stand now
por: Aravantinou-Fatorou, Aikaterini, et al.
Publicado: (2021)

Left Axillary Access for Transcatheter Aortic Valve Implantation in a Patient With Two Dependent Internal Mammary Artery Grafts and a Permanent Left-Sided Implanted Pacemaker
por: Papageorgiou, Christos, et al.
Publicado: (2023)

Oncological Patients With Endocrine Complications After Immunotherapy With Checkpoint Inhibitors Present Longer Progression-Free and Overall Survival
por: Paschou, Stavroula A., et al.
Publicado: (2022)

Advances in Gynecological Cancers
por: Liontos, Michalis, et al.
Publicado: (2022)

Multimodality imaging approach in a case of vascular toxicity caused by cabozantinib
por: Benetos, Georgios, et al.
Publicado: (2023)

PD-L1 Gene Polymorphisms rs822336 G>C and rs822337 T>A: Promising Prognostic Markers in Triple Negative Breast Cancer Patients
por: Makrantonakis, Andreas-Evangelos, et al.
Publicado: (2022)

Subarachnoid hemorrhage in a postpartum mother: A rare manifestation of an uncommon disease
por: Fiste, Oraianthi, et al.
Publicado: (2022)

What to expect from paraneoplastic syndromes of the nervous system in uterine cancer: A review of the literature
por: Svarna, Anna, et al.
Publicado: (2023)

Cancer in pregnancy: disentangling treatment modalities
por: Zagouri, Flora, et al.
Publicado: (2016)

Supportive medication in cancer during pregnancy
por: Zagouri, Flora, et al.
Publicado: (2020)

Endometrial Cancer: What Is New in Adjuvant and Molecularly Targeted Therapy?
por: Zagouri, Flora, et al.
Publicado: (2010)

Optimal Time Interval between Neoadjuvant Platinum-Based Chemotherapy and Interval Debulking Surgery in High-Grade Serous Ovarian Cancer
por: Andrikopoulou, Angeliki, et al.
Publicado: (2023)

Epothilones in epithelial ovarian, fallopian tube, or primary peritoneal cancer: a systematic review
por: Zagouri, Flora, et al.
Publicado: (2015)

The Genomic Profile of Pregnancy-Associated Breast Cancer: A Systematic Review
por: Korakiti, Anna-Maria, et al.
Publicado: (2020)

Time-related aortic inflammatory response, as assessed with (18)F-FDG PET/CT, in patients hospitalized with severely or critical COVID-19: the COVAIR study
por: Vlachopoulos, Charalambos, et al.
Publicado: (2022)

Physical Exercise Restrains Cancer Progression through Muscle-Derived Factors
por: Papadopetraki, Argyro, et al.
Publicado: (2022)

Germline and somatic variants in ovarian carcinoma: A next-generation sequencing (NGS) analysis
por: Andrikopoulou, Angeliki, et al.
Publicado: (2022)

Gestational trophoblastic neoplasia with retroperitoneal metastases: A fatal complication
por: Thomakos, Nikolaos, et al.
Publicado: (2010)

Treatment with abiraterone or enzalutamide does not impair immunological response to COVID-19 vaccination in prostate cancer patients
por: Liontos, Michalis, et al.
Publicado: (2021)

A Recalcitrant Electrical Storm and Implantable Defibrillator Exhaustion: Treatment Implications According to and Beyond Guidelines
por: Kontogiannis, Christos, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_1lu2g4ggv0q85rmcf3sd57jmvq